Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.79M Buy
338,520
+10,360
+3% +$119K 0.14% 18
2026
Q1
$4.17M Buy
328,160
+10,514
+3% +$128K 0.24% 19
2025
Q4
$4.01M Sell
317,646
-5,723
-2% -$63.3K 0.24% 18
2025
Q3
$2.95M Sell
323,369
-21,893
-6% -$225K 0.43% 17
2025
Q2
$3.68M Sell
345,262
-7,667
-2% -$85.6K 0.55% 15
2025
Q1
$3.87M Sell
352,929
-1,225
-0.3% -$14.2K 2.38% 15
2024
Q4
$4.44M Buy
354,154
+69,021
+24% +$752K 2.6% 13
2024
Q3
$2.44M Buy
285,133
+69,187
+32% +$559K 0.77% 21
2024
Q2
$1.76M Buy
215,946
+20,369
+10% +$186K 0.55% 35
2024
Q1
$1.73M Buy
195,577
+7,341
+4% +$62.3K 0.61% 29
2023
Q4
$1.77M Buy
+188,236
New +$1.54M 0.69% 28

Other funds holding CRESY

Glenorchy Capital's CRESY Position: Q2 2026 in Review

Glenorchy Capital increased its Cresud (CRESY) stake by 3.2% in Q2 2026, buying an estimated $119K and bringing the position to 338,520 shares worth $3.79M. The position accounts for 0.14% of the portfolio, ranked #18.

Glenorchy Capital first reported a position in CRESY in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.44M in Q4 2024. 15 funds tracked by Wall St. Rank hold CRESY as of Q2 2026.

  • Glenorchy Capital held 338,520 shares of Cresud worth $3.79M as of Q2 2026.
  • Glenorchy Capital bought 10,360 Cresud shares in Q2 2026, an estimated $119K.
  • Cresud made up 0.14% of Glenorchy Capital's portfolio in Q2 2026, its #18 holding.
  • Glenorchy Capital first reported a position in Cresud in Q4 2023 and has held it in 11 quarters since.
  • Glenorchy Capital's Cresud position peaked at $4.44M in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Cresud as of Q2 2026.

Based on Glenorchy Capital's 13F filing for Q2 2026, filed 29 Jul 2026.